EMEA-000234-PIP02-14
Key facts
| Invented name |
Cervarix
|
| Active substance |
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0008/2015
|
| PIP number |
EMEA-000234-PIP02-14
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Prevention of infection by human papillomavirus
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
GlaxoSmithKline Biologicals S.A. (Belgium)
Tel. +1 438 899 8201 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|